Matthew R. Henn, SEE REMARKS: Seres Therapeutics MCRB Sell · Filed 25/11/18

Trade details

Type: Insider sale
Amount: $21,746.1
Shares · price: 1,257 sh · $17.30 a share
Held after: 7,527 sh
Stock: Seres Therapeutics MCRB
Person: Matthew R. HennSEE REMARKS
Trade date: 25/11/15
Filed: 25/11/18
Days to filing: 3 days

Sold 14.3% of holdings

Share of holding sold: 14.3%

Seres Therapeutics trades, last 26 weeks

What else happened in Seres Therapeutics around then

Filed or reported within 30 days of the trade day · 25/10/16~25/12/15

Matthew R. Henn's recent trades

Matthew R. HennSEE REMARKS
Sell10b5-1 planSeres Therapeutics
Sell10b5-1 plan
Seres Therapeutics
MCRB
$580
77 sh
$580
Filed 05/19
Traded 05/18
Matthew R. HennSEE REMARKS
Sell10b5-1 planSeres Therapeutics
Sell10b5-1 plan
Seres Therapeutics
MCRB
$754
89 sh
$754
Filed 02/18
Traded 02/15
Matthew R. HennSEE REMARKS
Sell10b5-1 planSeres Therapeutics
Sell10b5-1 plan
Seres Therapeutics
MCRB
$1,215
73 sh
$1,215
Filed 25/08/19
Traded 25/08/18
Matthew R. HennSEE REMARKS
Sell10b5-1 planSeres Therapeutics
Sell10b5-1 plan
Seres Therapeutics
MCRB
$561
77 sh
$561
Filed 25/05/19
Traded 25/05/16
Matthew R. HennSEE REMARKS
Sell10b5-1 planSeres Therapeutics
Sell10b5-1 plan
Seres Therapeutics
MCRB
$3,202
3,953 sh
$3,202
Filed 25/02/19
Traded 25/02/18

Matthew R. Henn, Officer — sold $21.7K of Seres Therapeutics MCRB · 14.3% of holdings · 10b5-1 plan | Whalegun